PBAX NASDAQ
Phoenix Biotech Acquisition Corp.
1W: -16.8%
1M: -47.5%
3M: -46.2%
1Y: -44.3%
$5.85
Last traded 2024-02-14 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$6M
+0.0% ▲
Total Liabilities
$8M
+0.0% ▲
Shareholders Equity
-$2M
+0.0% ▲
Cash & Investments
$3M
+0.0% ▲
Total Debt
$2M
+0.0% ▲
Net Debt
-$2M
+0.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2024 |
|---|---|---|---|
| — Assets — | |||
| Cash | $1M | $476K | $3M |
| Short-Term Investments | $0 | $0 | $0 |
| Cash & ST Investments | $1M | $476K | $3M |
| Net Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Current Assets | $262K | $225K | $387K |
| Total Current Assets | $1M | $42M | $4M |
| Property, Plant & Equip. | $0 | $0 | $2M |
| Goodwill & Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $178M | $0 | $0 |
| Other Non-Current Assets | $148K | $0 | $500K |
| Total Non-Current Assets | $179M | $0 | $2M |
| Total Assets | $180M | $42M | $6M |
| — Liabilities — | |||
| Accounts Payable | $14K | $2M | $5M |
| Short-Term Debt | $0 | $650K | $876K |
| Deferred Revenue | $0 | $0 | $0 |
| Other Current Liabilities | $84K | $28M | $2M |
| Total Current Liabilities | $98K | $31M | $7M |
| Long-Term Debt | $0 | $0 | $699K |
| Other Non-Current Liab. | $0 | $9M | $0 |
| Total Non-Current Liabilities | $9M | $9M | $699K |
| Total Liabilities | $9M | $40M | $8M |
| — Equity — | |||
| Common Stock | $179M | $13M | $86K |
| Retained Earnings | -$8M | -$11M | -$71M |
| Accumulated OCI | $0 | $0 | $0 |
| Total Stockholders Equity | $171M | $2M | -$2M |
| Total Liabilities & Equity | $180M | $42M | $6M |
| — Key Metrics — | |||
| Total Debt | $0 | $650K | $2M |
| Net Debt | -$1M | $174K | -$2M |
| Total Investments | $178M | $0 | $0 |